SUPPLEMENT

Q1 2020 — Income statement trends

Q1 2020PDF · 2 pages137 KB
CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF GAAP INCOME
QUARTER ENDED
(dollars in millions, except per share data; shares in thousands)
Q118 	Q218 	Q318 	Q418 	Q119 	Q219 	Q319 	Q419 	Q120
Revenues:
Clearing and transaction fees 	973.6 	906.1 	752.5 	1,034.8 	952.6 	1,051.8 	1,040.7 	901.0 	1,278.8
Market data and information services 	94.9 	113.8 	110.7 	130.2 	130.1 	128.3 	129.8 	130.3 	131.5
Other Revenue 	40.5 	39.7 	41.0 	71.6 	96.9 	92.6 	106.8 	107.1 	111.8
Total revenues 	1,109.0 	1,059.6 	904.2 	1,236.6 	1,179.6 	1,272.7 	1,277.3 	1,138.4 	1,522.1
Expenses:
Compensation and benefits 	152.7 	150.8 	144.9 	223.8 	230.3 	227.3 	223.5 	217.6 	207.5
Technology 	25.5 	25.2 	24.7 	41.8 	47.1 	48.6 	52.7 	53.1 	47.7
Professional fees and outside services 	42.6 	31.9 	31.3 	60.3 	39.4 	41.7 	43.2 	49.8 	41.7
Amortization of purchased intangibles 	23.7 	23.6 	23.7 	59.0 	80.7 	76.1 	79.8 	78.1 	77.3
Depreciation and amortization 	28.1 	27.5 	30.2 	32.9 	32.9 	46.3 	41.4 	38.0 	35.3
Licensing and other fee agreements 	49.5 	39.9 	33.4 	47.8 	40.5 	44.8 	45.6 	41.3 	73.9
Other expense 	46.0 	93.8 	66.1 	121.1 	77.7 	89.3 	105.9 	87.5 	78.8
Operating expenses 	368.1 	392.7 	354.3 	586.7 	548.6 	574.1 	592.1 	565.4 	562.2
Operating Income 	740.9 	666.9 	549.9 	649.9 	631.0 	698.6 	685.2 	573.0 	959.9
Operating Margin 	67% 	63% 	61% 	53% 	53% 	55% 	54% 	50% 	63%
Non-operating Income and Expense
Investment income 	156.4 	241.9 	161.5 	185.3 	178.7 	139.3 	172.3 	147.6 	95.9
Interest and other borrowing costs 	(30.1) 	(33.1) 	(45.0) 	(49.5) 	(48.1) 	(45.1) 	(42.8) 	(42.0) 	(40.9)
Equity in net gains (losses) of unconsolidated subsidiaries 	40.1 	36.4 	37.1 	39.2 	40.5 	43.8 	48.0 	44.5 	51.2
Other non-operating income (expense) 	(118.6) 	(155.3) 	(141.7) 	(154.4) 	(161.9) 	(134.5) 	(139.5) 	(99.0) 	(76.8)
Non-operating income (expense) 	47.8 	89.9 	11.9 	20.6 	9.2 	3.5 	38.0 	51.1 	29.4
Income before income taxes 	788.7 	756.8 	561.8 	670.5 	640.2 	702.1 	723.2 	624.1 	989.3
Income taxes 	189.9 	190.7 	150.0 	283.5 	144.3 	187.5 	86.9 	155.1 	222.5
Net income 	598.8 	566.1 	411.8 	387.0 	495.9 	514.6 	636.3 	469.0 	766.8
Less: net income (loss) attributable to NCI 	- 	- 	- 	1.5 	(1.0) 	0.8 	- 	(0.5) 	0.6
Net Income Attributable to CME Group 	598.8 	566.1 	411.8 	385.5 	496.9 	513.8 	636.3 	469.5 	766.2
Effective Tax Rate 	24% 	25.2% 	26.7% 	42.3% 	22.5% 	26.7% 	12.0% 	24.9% 	22.5%
Earnings per Share:
Basic EPS 	1.76 	1.67 	1.21 	1.10 	1.39 	1.44 	1.78 	1.31 	2.14
Diluted EPS 	1.76 	1.66 	1.21 	1.09 	1.39 	1.43 	1.78 	1.31 	2.14
Weighted average number of common stock shares:
Basic Shares 	339,305 	339,465 	339,586 	350,921 	356,886 	357,060 	357,211 	357,456 	357,524
Diluted Shares 	340,747 	340,872 	341,035 	352,132 	358,047 	358,155 	358,369 	358,354 	358,455

-- 1 of 2 --

CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF NON-GAAP INCOME
QUARTER ENDED
(dollars in millions, except per share data; shares in thousands)
Q118 	Q218 	Q318 	Q418 	Q119 	Q219 	Q319 	Q419 	Q120
Revenues:
Clearing and transaction fees 	973.6 	906.1 	752.5 	1,034.8 	952.6 	1,051.8 	1,040.7 	901.0 	1,278.8
Market data and information services 	94.9 	113.8 	110.7 	130.2 	130.1 	128.3 	129.8 	130.3 	131.5
Other Revenue 	40.5 	39.7 	41.0 	71.6 	96.9 	92.6 	106.8 	107.1 	111.8
Total revenues 	1,109.0 	1,059.6 	904.2 	1,236.6 	1,179.6 	1,272.7 	1,277.3 	1,138.4 	1,522.1
Expenses:
Compensation and benefits 	151.0 	148.5 	142.2 	199.9 	219.7 	218.7 	219.2 	207.1 	210.9
Technology 	25.5 	25.2 	24.7 	41.8 	47.1 	48.1 	52.5 	51.5 	47.3
Professional fees and outside services 	24.4 	25.8 	24.9 	32.6 	33.7 	36.0 	37.1 	41.4 	35.3
Amortization of purchased intangibles 	- 	- 	- 	- 	- 	- 	- 	- 	-
Depreciation and amortization 	28.1 	27.5 	26.2 	28.9 	32.9 	35.7 	34.3 	35.1 	34.5
Licensing and other fee agreements 	49.5 	39.9 	33.4 	47.8 	40.5 	44.8 	45.6 	41.3 	73.9
Other expense 	44.4 	45.6 	43.4 	81.4 	69.4 	67.5 	66.4 	83.8 	57.6
Operating expenses 	322.9 	312.5 	294.8 	432.4 	443.3 	450.8 	455.1 	460.2 	459.5
Operating Income 	786.1 	747.1 	609.4 	804.2 	736.3 	821.9 	822.2 	678.2 	1,062.6
Operating Margin 	71% 	71% 	67% 	65% 	62% 	65% 	64% 	60% 	70%
Non-operating Income and Expense
Investment income 	155.0 	151.3 	161.0 	179.4 	176.7 	161.0 	165.4 	126.1 	102.3
Interest and other borrowing costs 	(29.9) 	(29.3) 	(30.1) 	(43.9) 	(48.1) 	(45.1) 	(42.8) 	(42.0) 	(42.6)
Equity in net gains (losses) of unconsolidated subsidiaries 	40.1 	36.4 	37.1 	39.2 	40.5 	43.8 	48.0 	44.5 	51.2
Other non-operating income (expense) 	(118.6) 	(118.4) 	(127.2) 	(143.5) 	(147.5) 	(132.2) 	(138.3) 	(99.2) 	(78.3)
Non-operating income (expense) 	46.6 	40.0 	40.8 	31.2 	21.6 	27.5 	32.3 	29.4 	32.6
Income before income taxes 	832.7 	787.1 	650.2 	835.4 	757.9 	849.4 	854.5 	707.6 	1,095.2
Income taxes 	199.2 	195.7 	155.2 	209.4 	179.7 	217.0 	175.3 	163.7 	258.8
Net income 	633.5 	591.4 	495.0 	626.0 	578.2 	632.4 	679.2 	543.9 	836.4
Less: net income (loss) attributable to NCI 	- 	- 	- 	1.5 	(1.0) 	0.8 	- 	(0.5) 	0.6
Net Income Attributable to CME Group 	633.5 	591.4 	495.0 	624.5 	579.2 	631.6 	679.2 	544.4 	835.8
Effective Tax Rate 	23.9% 	24.9% 	23.8% 	25.1% 	23.7% 	25.6% 	20.5% 	23.1% 	23.6%
Earnings per Share:
Basic EPS 	1.87 	1.74 	1.46 	1.78 	1.62 	1.77 	1.90 	1.52 	2.34
Diluted EPS 	1.86 	1.74 	1.45 	1.77 	1.62 	1.76 	1.90 	1.52 	2.33
Weighted average number of common stock shares:
Basic Shares 	339,305 	339,465 	339,586 	350,921 	356,886 	357,060 	357,211 	357,456 	357,524
Diluted Shares 	340,747 	340,872 	341,035 	352,132 	358,047 	358,155 	358,369 	358,354 	358,455

-- 2 of 2 --